Author: Myra Varnado, BS, RN, CWOCN
Skin substitutes (also called tissuebased products and dermal replacements) are a boon to chronic wound . . .Read More
Author: Heather Hettrick, PT, PhD, CWS, CLT, CLWT
Imagine you have a health condition that affects your life every day. Then imagine being . . .Read More
Author: Tara Slagle, MSN, BSN, RN
It’s been a stressful day at work—nothing new. One confused patient pulled off . . .Read More
Author: Jeri Lundgren, BSN, RN, PHN, CWS, CWCN
On April 13, 2016, the National Pressure Ulcer Advisory Panel (NPUAP) announced changes in pressure . . .Read More
Author: Kulbir Dhillon, NP, WCC
The goal of wound-bed preparation is to create a stable, well-vascularized environment that . . .Read More
Which statement about hyperglycemia and mortality in patients receiving nutritional support is correct?
a. Compared to parenteral nutrition (PN), general nutrition (EN) increases hyperglycemia risk nearly twofold.
b. Compared to EN, PN increases hyperglycemia risk nearly twofold.
c. Patients whose blood glucose (BG) level stays above 220 mg/dL during PN therapy have an increased risk of death.
d. Patients whose blood glucose (BG) level stays above 220 mg/dL during PN therapy have a decreased risk of death.
Correct answer: b. Experts estimate that up to 30% of patients receiving EN and more than 50% of those receiving PN develop hyperglycemia, defined as a BG level above 200 mg/ dL. Compared to EN, PN increases hyperglycemia risk nearly twofold, even when caloric intake is similar. One study found inadequate glucose control both before and during nutrition therapy predicted a higher mortality risk.
Learn more by reading “Supplemental nutrition in hospitalized patients with diabetes“